Short answer
Benitec Biopharma Inc. (BNTC) filed an 8-K current report with the SEC on May 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal quarter ended March 31, 2026 results announced May 14, 2026.
Benitec Biopharma Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended March 31, 2026 results announced May 14, 2026
- Operational update included alongside quarterly financial results
- Detailed financial figures and company commentary available in Exhibit 99.1 press release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Benitec Biopharma Inc. 8-K filings
Get the next BNTC 8-K as it lands
Follow BNTC for push alerts, or ask the research agent what this filing means.